# Phase 0.1.1 Final Schema-Integrity & Architectural-Consistency Audit Report

**Phase**: 0.1.1 Remediation Pass (Final Pre-Phase-1 Schema Integrity Pass)  
**Standard**: AAS-2026-NEURO-V1 / AAS-2026-NEURO-V2  
**Date**: September 26, 2026  
**Auditor**: Lead Technical Architect, Scientific Visualization Engineer & Digital Neuroanatomy Specialist  
**Repository**: `https://github.com/utkalpatel1012/neuro-atlas-3d`  
**Current HEAD**: Synchronized with `origin/main`  

---

## 1. Executive Summary & Final Verdict

Phase 0.1.1 was commissioned as an independent, rigorous architectural and scientific audit pass following Phase 0.1. Its explicit mandate was to resolve residual schema inconsistencies, eliminate simulated or fabricated asset provenance, enforce semantic safety in spatial transformations, decouple epistemic entity provenance from material 3D asset files, and establish a permanent set of architectural invariants prior to commencing Phase 1 (3D anatomical asset pipeline).

### FINAL PRE-PHASE-1 STATUS

```
================================================================================
FINAL PRE-PHASE-1 STATUS: READY_FOR_PHASE_1
================================================================================
```

**Justification for `READY_FOR_PHASE_1`**:
1. **Complete Polymorphic Ontology**: The `NeuroEntity` discriminated union contains all eight declared members (`AnatomicalStructure`, `CorticalParcelEntity`, `WhiteMatterTractEntity`, `FunctionalNetworkEntity`, `NeuralPathwayEntity`, `NeuromodulationTargetEntity`, `LesionModelEntity`, and `EvidenceClaimEntity`), each with a concrete, strongly-typed interface enabling exhaustive compiler narrowing without unsafe type assertions.
2. **Decoupled Provenance Architecture**: Physical asset provenance (`AssetProvenance`) is strictly separated from ontological/scientific provenance (`EntityProvenance`). Graph entities (such as functional networks, neural circuits, and evidence claims) are fully valid without physical 3D mesh files.
3. **Zero Fabricated Asset Provenance**: All placeholder SHA-256 strings (e.g., the empty-string SHA-256 hash `e3b0c44...`) and simulated pipeline git commit hashes (`d03cacf`) have been completely purged from the repository. Pre-pipeline assets explicitly declare `resulting_sha256_hash: "NOT_YET_GENERATED"` and `validation_status: "PENDING"`.
4. **Semantically Safe Coordinates**: In TypeScript types (`SpatialCoordinate` and `SpatialDescriptor`), registered coordinates are strictly coupled to their target coordinate frame and `RegistrationMetadata`. It is a compile-time error to declare a registered coordinate without declaring its target reference template, registration method, and uncertainty metric.
5. **Contextual Scientific Evidence Model**: Evidence claims declare explicit `evidence_domain` and `evidence_assessment_framework` fields. Clinical claims are graded via GRADE; pure gross anatomical morphology is evaluated under `QUALITATIVE_ANATOMICAL_CONSENSUS`; and translational hypotheses are classified as `COMPUTATIONAL_THEORETICAL` / `PRECLINICAL` without inappropriate clinical GRADE labeling.
6. **Fully Validated Exemplar**: `data/structures/hippocampus_left.json` complies with all hardened schemas and passes automated deep validation tests.
7. **Passing Test Suite**: `npm test` (`tsx src/schema_validation.test.ts`) and `npm run typecheck` (`tsc --noEmit`) pass with zero errors.

---

## 2. Problems Found in Post-Phase-0.1 Repository

Our targeted audit identified seven specific residual architectural weaknesses:

| Defect ID | Severity | Location | Specific Architectural Issue |
| :--- | :--- | :--- | :--- |
| **DEF-01** | **HIGH** | `src/types/entity.ts` | **NeuroEntity Discriminated Union Incompleteness**: `NeuroEntityType` declared 8 string literals, but `NeuroEntity` union only included 5 types. Missing: `AnatomicalStructure`, `NeuromodulationTargetEntity`, and `EvidenceClaimEntity`. Exhaustive switch-case narrowing was impossible. |
| **DEF-02** | **HIGH** | `src/types/entity.ts`, `src/types/provenance.ts` | **Entity vs. Asset Provenance Conflation**: `BaseNeuroEntity` mandated `provenance: AssetProvenance`. Non-physical entities (evidence claims, functional networks, pathways) were forced to simulate 3D mesh files, decimation steps, and SHA-256 hashes. |
| **DEF-03** | **HIGH** | `data/structures/hippocampus_left.json` | **Fabricated Production Provenance**: The hippocampus exemplar contained the SHA-256 digest of an empty string (`e3b0c44...`) and simulated git commits (`d03cacf`), falsely presenting pre-pipeline candidate geometry as processed production assets. |
| **DEF-04** | **MEDIUM** | `src/types/coordinates.ts` | **Coordinate Decoupling Vulnerability**: `RegisteredCoordinate` allowed optional `registered_coordinate` without mandating `registered_coordinate_frame` or `registration` metadata, allowing invalid spatial states. |
| **DEF-05** | **MEDIUM** | `src/types/evidence.ts`, `data/structures/hippocampus_left.json` | **Inappropriate Epistemic Framework Application**: Purely anatomical or basic rodent hypotheses were forced into the clinical GRADE framework, distorting evidence standards. |
| **DEF-06** | **MEDIUM** | `src/types/neuromodulation.ts` | **Frozen Regulatory Enums**: Regulatory clearance was encoded as an immutable TypeScript enum (`FDA_CLEARED_FIRST_LINE`), failing to support multi-jurisdictional clearances or evolving device classifications. |
| **DEF-07** | **LOW** | `src/types/pharmacology.ts` | **Subjective Receptor Density**: Qualitative density labels (`very_high`, `high`) lacked experimental measurement methodology context (autoradiography vs PET BP_ND vs snRNA-seq). |

---

## 3. Corrections Made

### 3.1. Concrete Interfaces for All 8 Entity Types (`src/types/entity.ts`)
Created concrete interfaces for every member of `NeuroEntityType`:
1. `AnatomicalStructure` (imported from `./anatomy`)
2. `CorticalParcelEntity`
3. `WhiteMatterTractEntity`
4. `FunctionalNetworkEntity`
5. `NeuralPathwayEntity`
6. `NeuromodulationTargetEntity` (new concrete interface referencing underlying anatomical structures and stereotaxic coordinates)
7. `LesionModelEntity`
8. `EvidenceClaimEntity` (new concrete interface anchoring epistemic graph nodes)

The `NeuroEntity` discriminated union is now complete and exhaustively narrowed via `switch (entity.entity_type)`.

### 3.2. Decoupled Entity Provenance from Physical Asset Provenance (`src/types/provenance.ts`)
* Introduced `EntityProvenance`:
  * Tracks `source_authority`, `dataset_name`, `dataset_version`, `ontology_reference`, `citation_keys`, `provenance_notes`, and `last_reviewed`.
* Refactored `AssetProvenance`:
  * Reserved strictly for physical/material files (`.glb`, `.ktx2`, displacement maps).
  * State model standardized to: `UNVERIFIED | PENDING | VERIFIED | CLEARED | RESTRICTED`.
  * `resulting_sha256_hash`: Permits `"NOT_YET_GENERATED"` for pre-pipeline candidate geometry.
* Refactored `BaseNeuroEntity`:
  * Requires `provenance: EntityProvenance`.
  * Physical meshes are optionally linked via `asset_id?: string` and `asset_provenance?: AssetProvenance`. Non-physical entities (e.g., Default Mode Network, evidence claims) exist without 3D files.

### 3.3. Elimination of False Asset Provenance (`data/structures/hippocampus_left.json`)
* Removed the fake SHA-256 hash (`e3b0c44...`) and dummy commit hashes (`d03cacf`).
* In `hippocampus_left.json`, `asset_provenance.modifications_applied` is set to `[]`.
* `asset_provenance.resulting_sha256_hash` is explicitly set to `"NOT_YET_GENERATED"`.
* `asset_provenance.validation_status` is set to `"PENDING"`, indicating that mesh decimation, manifold check, and cryptographic hashing are deferred to the Phase-1 asset pipeline.

### 3.4. Semantic Safety in Coordinate Transformations (`src/types/coordinates.ts`)
* Partitioned coordinate frames into `VolumetricCoordinateFrame` and `SurfaceCoordinateFrame`.
* Created `StereotaxicRegistrationRecord`:
  ```ts
  export interface StereotaxicRegistrationRecord {
    registered_coordinate: [number, number, number];
    registered_coordinate_frame: CoordinateFrame;
    registration: RegistrationMetadata;
  }
  ```
* Created discriminated `SpatialCoordinate`:
  * `status: 'unregistered'` $\rightarrow$ only source coordinate and frame.
  * `status: 'registered'` $\rightarrow$ requires coupled `stereotaxic: StereotaxicRegistrationRecord`.
* In `SpatialDescriptor`, `stereotaxic_registration` couples `registered_centroid`, `registered_coordinate_frame`, and `registration` into an atomic sub-object.

### 3.5. Multi-Domain Scientific Evidence Model (`src/types/evidence.ts`)
* Introduced `EvidenceDomain`: `anatomical | functional | mechanistic | clinical | pharmacological | neuromodulatory`.
* Introduced `EvidenceAssessmentFramework`: `GRADE | OXFORD_CEBM | QUALITATIVE_ANATOMICAL_CONSENSUS | PRECLINICAL_EXPERIMENTAL_VALIDATION | COMPUTATIONAL_THEORETICAL`.
* In `hippocampus_left.json`:
  * MDD volume reduction claim $\rightarrow$ `evidence_domain: "clinical"`, `framework: "GRADE"`, `certainty: "GRADE_HIGH"`.
  * Neurogenesis hypothesis $\rightarrow$ `evidence_domain: "mechanistic"`, `framework: "COMPUTATIONAL_THEORETICAL"`, `certainty: "NOT_APPLICABLE_NON_CLINICAL"`.
  * Scoville & Milner bilateral lesion claim $\rightarrow$ `evidence_domain: "clinical"`, `framework: "OXFORD_CEBM"`, `certainty: "GRADE_HIGH"`.

### 3.6. Extensible Neuromodulation Regulatory Records (`src/types/neuromodulation.ts`)
* Replaced brittle frozen enum with extensible `RegulatoryClearance` records:
  * Captures `jurisdiction`, `regulatory_agency`, `status_category`, `formal_indication_label`, `cleared_device_examples`, `approval_or_clearance_year`, `regulatory_identifier`, and `guideline_reference`.
* Maintained legacy type aliases for backwards compatibility.

### 3.7. Quantitative Receptor Density Context (`src/types/pharmacology.ts`)
* Added `DensityMeasurementMethod`: `autoradiography_radioligand | pet_in_vivo_binding_potential | mrna_microarray_allen_human | single_nucleus_rna_seq | immunohistochemistry_semiquant`.
* Added `ReceptorDensityProfile` capturing measurement method, quantitative value ($K_i, \text{IC}_{50}, \text{EC}_{50}$), unit, species, and tissue source.

---

## 4. New Architectural Documents Created

1. [`ARCHITECTURAL_INVARIANTS.md`](./ARCHITECTURAL_INVARIANTS.md):
   * Establishes the **Ten Core Mandates** preventing AI agents and engineers from conflating anatomy with assets, anatomy with parcels, networks with pathways, coordinates, or research datasets.
2. [`ENTITY_IDENTITY_AND_REFERENCING.md`](./ENTITY_IDENTITY_AND_REFERENCING.md):
   * Establishes the deterministic URI taxonomy across eight strictly partitioned namespaces (`brain.*`, `parcel.*`, `mesh.*`, `claim.*`, `network.*`, `pathway.*`, `target.*`, `lesion.*`).

---

## 5. Automated Validation & Test Suite

Created [`src/schema_validation.test.ts`](./src/schema_validation.test.ts) executed via `npm test` (`tsx src/schema_validation.test.ts`):

```
====================================================
PHASE 0.1.1 SCHEMA INTEGRITY TEST SUITE
====================================================
[PASS 1] Exhaustive union narrowing verified for all entity types.
[PASS 2] Non-physical entities (FunctionalNetwork, EvidenceClaim) validated without physical 3D meshes.
[PASS 3] NeuromodulationTargetEntity references underlying anatomical structures and coordinates.
[PASS 4] SpatialCoordinate discriminated union enforces registration metadata.
[PASS 5] AssetProvenance honors PENDING status and NOT_YET_GENERATED hash without false claims.
[PASS 6] AnatomicalStructure correctly narrowed in NeuroEntity union: "Structure: Hippocampus (Left) (Hippocampus)".
[PASS 7] Exemplar data/structures/hippocampus_left.json passed complete structural and scientific audit.
====================================================
RESULT: All Phase 0.1.1 schema validation and architectural invariant checks PASSED.
====================================================
```

Static TypeScript compilation via `npm run typecheck` (`tsc --noEmit`):
* Mode: Strict Mode (`strict: true`, `noUnusedLocals: true`, `noUnusedParameters: true`, `noFallthroughCasesInSwitch: true`).
* Result: **0 errors, 0 warnings**.

---

## 6. Remaining Risks & Intentional Phase 1 Deferrals

### Risks Under Control
1. **ShareAlike Viral Scope**: Addressed in `SOURCES_AND_LICENSES.md`. Application code remains Apache-2.0; derivative 3D meshes will be distributed under CC-BY-SA 4.0.
2. **HCP Commercial Clearance**: Governed by `LEGAL_REVIEW_REQUIRED` status in asset manifest.
3. **iPadOS Jetsam Memory Ceiling**: Enforced by 110 MB GPU memory budget on base iPad (`PERFORMANCE_BUDGETS.md`).

### Intentionally Deferred to Phase 1
1. **Actual 3D Mesh Ingestion & Cleaning**: Ingestion of candidate Z-Anatomy `.blend` / `.obj` files, non-manifold repairing, centroid centering, and QEM decimation scripts.
2. **Cryptographic SHA-256 Hash Generation**: Computation of final SHA-256 digests once processed `.glb` assets are generated by the asset pipeline.
3. **Three.js WebGPURenderer Implementation**: Scene construction, camera rigging, shader compilation, and BVH acceleration structures.
4. **Complete Anatomical Catalogue Population**: Transitioning planned structures from `PLANNED` through `SOURCE_IDENTIFIED` to `MESH_AVAILABLE`.

---

## 7. Hard Stop Confirmation

In accordance with Phase 0.1.1 instructions, the following boundaries have been strictly observed:
* **NO** production anatomical meshes were imported.
* **NO** large datasets were downloaded.
* **NO** Blender assets or GLB files were generated.
* **NO** production 3D renderer or Three.js scene code was created.
* **NO** placeholder or fake anatomical geometry was introduced.

The repository is frozen in a clean, strongly-typed, scientifically coherent state, fully prepared for Phase 1.
